Solventum Corporation
General ticker "SOLV" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $12.8B (TTM average)
Solventum Corporation follows the US Stock Market performance with the rate: 25.9%.
Estimated limits based on current volatility of 1.4%: low 74.44$, high 76.58$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 20584 (+87.1%) as of 2025
- US accounted for 57.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Management distraction, Spin off risks (transition costs), 3M dependency, System integration, Geopolitical risks
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [67.93$, 93.84$]
- 2026-12-31 to 2027-12-31 estimated range: [70.71$, 97.44$]
Short-term SOLV quotes
Long-term SOLV plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $8,253.00MM | $8,254.00MM | $8,325.00MM |
| Operating Expenses | $6,561.00MM | $7,218.00MM | $6,144.00MM |
| Operating Income | $1,692.00MM | $1,036.00MM | $2,181.00MM |
| Non-Operating Income | $-25.00MM | $-431.00MM | $-468.00MM |
| Interest Expense | $0.00MM | $367.00MM | $347.00MM |
| R&D Expense | $758.00MM | $775.00MM | $739.00MM |
| Income(Loss) | $1,667.00MM | $605.00MM | $1,713.00MM |
| Taxes | $321.00MM | $127.00MM | $157.00MM |
| Net Income(Loss)* | $1,346.00MM | $479.00MM | $1,556.00MM |
| Stockholders Equity | $11,666.00MM | $2,959.00MM | $5,049.00MM |
| Inventory | $857.00MM | $965.00MM | $1,066.00MM |
| Assets | $13,943.00MM | $14,457.00MM | $14,294.00MM |
| Operating Cash Flow | $1,915.00MM | $1,185.00MM | $369.00MM |
| Capital expenditure | $290.00MM | $380.00MM | $379.00MM |
| Investing Cash Flow | $-230.00MM | $-380.00MM | $2,797.00MM |
| Financing Cash Flow | $-1,552.00MM | $-240.00MM | $-3,057.00MM |
| Earnings Per Share** | $7.79 | $2.77 | $8.94 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.